Management of primary and metastatic triple negative breast cancer: Perceptions of oncologists from India.

Simple item page
dc.contributor.authorParikh, P M
dc.contributor.authorGupta, S
dc.contributor.authorParikh, B
dc.contributor.authorSmruti, B K
dc.contributor.authorIssrani, J
dc.contributor.authorTopiwala, S
dc.contributor.authorGoswami, C
dc.contributor.authorBhattacharya, G S
dc.contributor.authorSen, T
dc.contributor.authorSekhon, J S
dc.contributor.authorMalhotra, H
dc.contributor.authorNag, S
dc.contributor.authorChacko, R T
dc.contributor.authorGovind, K Babu
dc.contributor.authorRaja, T
dc.contributor.authorVaid, A K
dc.contributor.authorDoval, D C
dc.contributor.authorGupta, S
dc.contributor.authorDas, P K
dc.date.accessioned2013-01-17T07:31:51Z
dc.date.available2013-01-17T07:31:51Z
dc.date.issued2011-04
dc.description.abstractBackground: In order to document the understanding of current evidence for the management of triple negative breast cancer and application of this knowledge in daily practice, we conducted an interactive survey of practicing Indian oncologists. Materials and Methods: A core group of academic oncologists devised two hypothetical triple negative cases (metastatic and early breast cancer, respectively) and multiple choice options under different clinical circumstances. The respondents were practicing oncologists in different Indian cities who participated in either an online survey or a meeting. The participants electronically chose their preferred option based on their everyday practice. Results: A total of 152 oncologists participated. Just over half (53.8%) preferred taxane based chemotherapy as first-line chemotherapy in the metastatic setting. In the adjuvant setting, a taxane regimen was chosen by 61%. Over half of respondents (52.6%) underestimated the baseline survival of a patient with node positive triple-negative tumor and 18.9% overestimated this survival compared to the estimate of the Adjuvant! program. Discussion: This data offers insight into the perceptions and practice of a diverse cross-section of practicing oncologists in India with respect to their therapeutic choices in metastatic and adjuvant settings in triple negative breast cancer.en_US
dc.identifier.citationParikh P M, Gupta S, Parikh B, Smruti B K, Issrani J, Topiwala S, Goswami C, Bhattacharya G S, Sen T, Sekhon J S, Malhotra H, Nag S, Chacko R T, Govind K Babu, Raja T, Vaid A K, Doval D C, Gupta S, Das P K. Management of primary and metastatic triple negative breast cancer: Perceptions of oncologists from India. Indian Journal of Cancer. 2011 Apr-Jun; 48(2): 158-164.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/144445
dc.language.isoenen_US
dc.source.urihttps://www.indianjcancer.com/article.asp?issn=0019-509X;year=2011;volume=48;issue=2;spage=158;epage=164;aulast=Parikhen_US
dc.subjectCurrent practicesen_US
dc.subjectchemotherapyen_US
dc.subjectsurveyen_US
dc.subject.meshAdult
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols --therapeutic use
dc.subject.meshBreast Neoplasms --drug therapy
dc.subject.meshBreast Neoplasms --pathology
dc.subject.meshChemotherapy, Adjuvant
dc.subject.meshCyclophosphamide --administration & dosage
dc.subject.meshDoxorubicin --administration & dosage
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshIndia
dc.subject.meshLung Neoplasms --drug therapy
dc.subject.meshLung Neoplasms --secondary
dc.subject.meshLymphatic Metastasis
dc.subject.meshMedical Oncology
dc.subject.meshMiddle Aged
dc.subject.meshPhysician's Practice Patterns
dc.subject.meshReceptor, erbB-2 --metabolism
dc.subject.meshReceptors, Estrogen --metabolism
dc.subject.meshSurvival Rate
dc.subject.meshTaxoids --administration & dosage
dc.subject.meshTreatment Outcome
dc.titleManagement of primary and metastatic triple negative breast cancer: Perceptions of oncologists from India.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijc2011v48n2p158.pdf
Size:
287.65 KB
Format:
Adobe Portable Document Format
Description:
Journal article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Indian Journal of Cancer